Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**CannaStrips** are dissolvable oral strips formulated as a safer alternative to smoking medical cannabis, delivering a concentrated and controlled dose of active cannabinoids, primarily THC, in each strip (typically 10mg per strip). They are placed under the lip or tongue for sublingual absorption, providing rapid onset effects similar to inhalation without combustion or odor. Marketed for medical cannabis users seeking precise dosing for symptom relief, they leverage the entourage effects of cannabis extracts for potential benefits in pain, nausea, and other conditions approved for medical marijuana, though not FDA-approved as a pharmaceutical.[1][18]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CannaStrips.